BELGIUM – PDC*line Pharma, a clinical-stage biotech company developing a new class of potent and scalable active off-the-shelf cancer vaccine, has completed its Series B2 round of funding, raising €17.5…
Read MorePDC*line Pharma raises US$20.3 million in Series B2 financing round
